<?xml version="1.0" encoding="UTF-8"?>
<p>HCV Ab prevalence in those exposed to PAT peaked in 2008 at 42.4% and declined slowly thereafter to 40.6% in 2018 (
 <xref ref-type="fig" rid="dyaa052-F3">Figure 3B</xref>). The number of HCV-prevalent infections (regardless of whether attributed to PAT or not) among those who have ever been exposed to PAT and alive was estimated at 1.9 million in 1980, 2.3 million in 2000 and 1.5 million in 2018 (
 <xref rid="dyaa052-T2" ref-type="table">Table 2</xref>). The proportion of individuals exposed to PAT among the total HCV Ab-positive population was growing and reached a peak of 35.5% in 1977, but declined thereafter to 26.5% by 2000 and 21.0% by 2018 (
 <xref ref-type="fig" rid="dyaa052-F3">Figure 3C</xref>).
</p>
